Legacy Wealth Management (Mississippi)’s Vertex Pharmaceuticals VRTX Stock Holding History

Legacy Wealth Management (Mississippi)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,196	Closed	-$241K	–	107
2021 Q2	$241K	Sell	1,196 -1,050	-47%	-$220K	0.13%	98
2021 Q1	$483K	Sell	2,246 -18	-0.8%	-$3.95K	0.29%	66
2020 Q4	$535K	Hold	2,264	–	–	0.34%	64
2020 Q3	$616K	Hold	2,264	–	–	0.42%	60
2020 Q2	$657K	Buy	2,264 +107	+5%	+$29K	0.5%	59
2020 Q1	$513K	Buy	+2,157	New	+$495K	0.48%	60

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legacy Wealth Management (Mississippi)'s VRTX Position: Q3 2021 in Review

Legacy Wealth Management (Mississippi) sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 1,196 shares — an estimated $241K sold.

Legacy Wealth Management (Mississippi) first reported a position in VRTX in Q1 2020 and held it in 6 quarters. The position peaked at $657K in Q2 2020. 933 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

Legacy Wealth Management (Mississippi) reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Legacy Wealth Management (Mississippi) sold 1,196 Vertex Pharmaceuticals shares in Q3 2021, an estimated $241K.
Legacy Wealth Management (Mississippi) first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 6 quarters.
Legacy Wealth Management (Mississippi)'s Vertex Pharmaceuticals position peaked at $657K in Q2 2020.
933 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Legacy Wealth Management (Mississippi)'s 13F filing for Q3 2021, filed 12 Dec 2024.